Candriam SCA’s Mineralys Therapeutics MLYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.2M Sell
824,187
-58,646
-7% -$794K 0.06% 233
2025
Q1
$14M Buy
882,833
+577,561
+189% +$9.17M 0.09% 202
2024
Q4
$3.76M Buy
+305,272
New +$3.76M 0.02% 397